Treatment with tofacitinib attenuates muscle loss through myogenin activation in the collagen-induced arthritis.
- DOI
- 10.1186/s42358-024-00416-5
- Published
- 2024 Nov 13
- Container
- Advances in rheumatology (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s42358-024-00416-5,
title = {Treatment with tofacitinib attenuates muscle loss through myogenin activation in the collagen-induced arthritis.},
author = {da Rosa TH and Bartikoski BJ and do Espírito Santo RC and Farinon M and de Souza Silva JM and Pedó RT and Gasparini ML and Karnopp T and Dos Santos LP and Chapacais G and di Domenico A and Loch S and Xavier RM},
year = {2024},
journal = {Advances in rheumatology (London, England)},
doi = {10.1186/s42358-024-00416-5},
url = {https://doi.org/10.1186/s42358-024-00416-5}
}RIS
TY - JOUR TI - Treatment with tofacitinib attenuates muscle loss through myogenin activation in the collagen-induced arthritis. AU - da Rosa TH AU - Bartikoski BJ AU - do Espírito Santo RC AU - Farinon M AU - de Souza Silva JM AU - Pedó RT AU - Gasparini ML AU - Karnopp T AU - Dos Santos LP AU - Chapacais G AU - di Domenico A AU - Loch S AU - Xavier RM PY - 2024 JO - Advances in rheumatology (London, England) DO - 10.1186/s42358-024-00416-5 UR - https://doi.org/10.1186/s42358-024-00416-5 ER -
APA
TH, D. R., BJ, B., RC, D. E. S., M, F., JM, D. S. S., RT, P., ML, G., T, K., LP, D. S., G, C., A, D. D., S, L., & RM, X. (2024). Treatment with tofacitinib attenuates muscle loss through myogenin activation in the collagen-induced arthritis.. Advances in rheumatology (London, England). https://doi.org/10.1186/s42358-024-00416-5
Source records
- pubmed · retrieved 2026-09-26T23:36:11.568Z